Back to trial details

Intake questionnaire

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Applying to UT Southwestern/Simmons Cancer Center-Dallas · Dallas, Texas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Autoimmune Disease?
3. Are you able to travel to Dallas for study visits?